ROYAL BANK OF CANADA - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 44 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
315
-97.5%
0.00%
Q2 2023$4,000
-20.0%
12,610
+16.4%
0.00%
Q1 2023$5,00010,831
+5315.5%
0.00%
Q4 2022$0
-100.0%
200
-91.2%
0.00%
Q3 2022$2,000
-75.0%
2,268
-42.2%
0.00%
Q1 2022$8,000
-11.1%
3,925
+80.9%
0.00%
Q3 2021$9,000
-69.0%
2,170
-60.7%
0.00%
Q2 2021$29,000
-56.1%
5,523
-61.2%
0.00%
Q1 2021$66,000
+3200.0%
14,229
+2745.8%
0.00%
Q4 2020$2,000
-98.5%
500
-98.8%
0.00%
Q3 2020$136,000
-3.5%
41,108
-1.7%
0.00%
Q2 2020$141,000
-35.9%
41,809
-27.6%
0.00%
Q1 2020$220,000
-29.0%
57,737
+12.5%
0.00%
Q4 2019$310,000
+0.6%
51,300
+25.7%
0.00%
Q3 2019$308,000
-48.3%
40,806
-7.2%
0.00%
Q2 2019$596,000
+172.1%
43,976
+8.7%
0.00%
Q1 2019$219,000
+265.0%
40,446
+100.4%
0.00%
Q4 2018$60,000
-86.3%
20,184
-63.8%
0.00%
Q3 2018$438,000
+3269.2%
55,819
+4028.6%
0.00%
Q2 2018$13,000
-64.9%
1,352
-68.9%
0.00%
Q1 2018$37,000
-47.1%
4,350
-21.5%
0.00%
Q4 2017$70,000
+191.7%
5,540
+91.8%
0.00%
Q3 2017$24,000
+1100.0%
2,888
+2574.1%
0.00%
Q2 2017$2,000108
+5300.0%
0.00%
Q1 2017$0
-100.0%
2
-98.0%
0.00%
Q4 2016$2,000
+100.0%
1000.0%0.00%
Q3 2015$1,0001000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 3,662,342$7,874,0000.16%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 213,469$438,0000.07%
GSA CAPITAL PARTNERS LLP 150,914$309,0000.04%
Bernardo Wealth Planning LLC 30,469$62,0000.03%
Penserra Capital Management LLC 351,154$719,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,900$361,0000.01%
Founders Capital Management 3,000$9,0000.01%
King Wealth Management Group 16,000$33,0000.01%
Aquatic Capital Management LLC 1,900$4,0000.01%
Newbridge Financial Services Group, Inc. 6,075$12,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders